Medicus Pharma (MDCX) Other Operating Expenses (2024 - 2025)

Medicus Pharma (MDCX) posted Other Operating Expenses of -$996039.0 for Q4 2025, up 40.88% quarter-over-quarter from -$1.7 million in Q3 2025.

Medicus Pharma (MDCX) Other Operating Expenses (2024 - 2025) Analysis & Trends

Medicus Pharma (MDCX) has reported Other Operating Expenses for 2 consecutive years, with -$996039.0 the latest figure, recorded in Q4 2025.

Other Operating Expenses for Q4 2025 came in at -$996039.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was -$2.7 million (down 575.2% YoY), and the FY2025 annual result was $7.7 million, changed N/A from the prior year.
Other Operating Expenses was -$996039.0 for Q4 2025 at Medicus Pharma, up from -$1.7 million in the prior quarter.
Over five years, Other Operating Expenses peaked at $564145.0 in Q3 2024 and troughed at -$1.7 million in Q3 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Eli Lilly	1,066.16 Bn	1,060.88 Bn	16.22 Bn
2	Johnson & Johnson	611.69 Bn	589.64 Bn	15.96 Bn
3	AbbVie	444.34 Bn	434.99 Bn	10.78 Bn
4	Astrazeneca	284.94 Bn	277.05 Bn	12.61 Bn
5	Merck	224.23 Bn	218.58 Bn	12.09 Bn
6	Amgen	195.12 Bn	183.08 Bn	5.87 Bn
7	Gilead Sciences	156.45 Bn	148.73 Bn	5.52 Bn
8	Pfizer	136.01 Bn	123.24 Bn	-1.21 Bn
9	Novartis Ag	113.45 Bn	113.67 Bn	-
10	Medicus Pharma	6.91 Mn	-1.69 Mn	-

Download Data